Skip to main content

Management of Multiorgan Failure After Artificial Organ Implantation

  • Chapter
  • First Online:
  • 1323 Accesses

Part of the book series: New Techniques in Surgery Series ((NEWTECHN,volume 4))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Weil MH, Shubin H. Proposed reclassification of shock states with special reference to distributive defects. Adv Exp Med Biol. 1971; 23: 13–23

    PubMed  CAS  Google Scholar 

  2. Choi  PTL, Yip G, Quinonez LG, Cook  DJ. Crystalloids vs. colloids in fluid resuscitation: A systematic review. Crit Care Med. 1999;27:200–210

    Article  PubMed  Google Scholar 

  3. Cook D, Guyatt G. Colloid use for fluid resuscitation: Evidence and spin. Ann Intern Med. 2001;135:205–208

    PubMed  CAS  Google Scholar 

  4. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: Asystematic review of randomized trials. BMJ. 1998;316:961–964

    PubMed  CAS  Google Scholar 

  5. Cook D, Guyatt G. Colloid use for fluid resuscitation: Evidence and spin. Ann Intern Med. 2001;135:205–208

    PubMed  CAS  Google Scholar 

  6. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911–916

    Article  PubMed  CAS  Google Scholar 

  7. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007;98:216–224

    Article  PubMed  CAS  Google Scholar 

  8. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256

    Article  PubMed  CAS  Google Scholar 

  9. Fang Jing MD a, Mensah George A MD a, Alderman Michael H MD b, Croft Janet B PhD a. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979–2003, United States. Am Heart J. December 2006;152(6):1035–1041.

    Google Scholar 

  10. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–634.

    Article  PubMed  CAS  Google Scholar 

  11. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail. 2002;4:515–529.

    Article  PubMed  CAS  Google Scholar 

  12. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006;34:589–597

    Article  PubMed  CAS  Google Scholar 

  13. Kohsaka S, Menon V, Lowe AM, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165:1643–1650.

    Article  PubMed  Google Scholar 

  14. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Ferrer-Hita JJ. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases. J Clin Pharmacol. 2005;45:704–708.

    Article  PubMed  CAS  Google Scholar 

  15. Ellger BM, Zahn PK, Van Aken HK, et al. Levosimendan: a promising treatment for myocardial stunning? Anaesthesia. 2006;61:61–63.

    Article  PubMed  CAS  Google Scholar 

  16. Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006;67:68–77.

    Article  PubMed  Google Scholar 

  17. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–1283.

    Article  PubMed  Google Scholar 

  18. Chen YS, Yu HY, Huang SC, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant. 2005;24:81–87

    Article  PubMed  Google Scholar 

  19. Dharnidharka VR, Stablein DM, Harmon WE.Post-Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCS. Am J Transplant. 2004;4(3):384–389

    Article  PubMed  Google Scholar 

  20. Sakr Y, Dubois MJ, De Backer D, Creteur J Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32(9)1825–31

    Article  PubMed  Google Scholar 

  21. LeDoux D, Astiz ME, Carpati CM, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729–2732

    Article  PubMed  CAS  Google Scholar 

  22. Dellinger PR, Levy MM, Carlet JM et al. for the International Surviving Sepsis Campaign Guidelines Committee Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. January 2008;36(1):296–327.

    Article  PubMed  Google Scholar 

  23. Regnier B, Rapin M, Gory G, et al. Haemodynamic effects of dopamine in septic shock. Intensive Care Med. 1977;3:47–53

    Article  PubMed  CAS  Google Scholar 

  24. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–2143

    Article  PubMed  CAS  Google Scholar 

  25. Russell J. Hemodynamic support of sepsis. Vasopressin versus norepinephrine for septic shock. Program and abstracts of the Society of Critical Care Medicine 36th Critical Care Congress. Orlando, Florida; February 17–21, 2007.

    Google Scholar 

  26. Dünser MW, Mayr AJ, Tura A, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors. Crit Care Med. 2003;31:1394–1398.

    Article  PubMed  Google Scholar 

  27. Rabuel C, Mebazza A. Septic Shock: a heart story since the 1960s . Intensive Care Med. 2006;32(6):799–807.

    Article  PubMed  CAS  Google Scholar 

  28. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871

    Article  PubMed  CAS  Google Scholar 

  29. Sprung CL, Annane D, Briegel J, et al: Corticosteroid therapy of septic shock (CORTICUS). Abstr. Am Rev Respir Crit Care Med. 2007;175:A507

    Google Scholar 

  30. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290:2301–12.

    Article  PubMed  CAS  Google Scholar 

  31. Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute pulmonary edema: systematic review and meta-analysis. JAMA. 294:3124–3130

    Google Scholar 

  32. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.

    Article  Google Scholar 

  33. Ferguson ND, Meade MO, Esteban A et al. Influence of Randomized Trials on usual Clinical Practice. The International Study of Mechanical Ventilation. Proc Am Thor Soc. 2006;3:A831

    Article  Google Scholar 

  34. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.

    Article  Google Scholar 

  35. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354:2213–24.

    Article  Google Scholar 

  36. Derdak S, Mehta S, Stewart TE, et al. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults. Am J Respir Crit Care Med. 2002;166:801–808.

    Article  PubMed  Google Scholar 

  37. The National Heart, Lung and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressure in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327–336.

    Article  Google Scholar 

  38. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005;353:2683–95.

    Article  PubMed  CAS  Google Scholar 

  39. AdhikariNK, Burns KE, Freidrich JO, Granton JT, Cook DJ, MeadeMO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta analysis. BMJ. 2007;334:779–82.

    Article  PubMed  Google Scholar 

  40. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, Malacrida R, Di Giulio P, Fumagalli R, Pelosi P, Brazzi L, Latini R, Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345: 568-573.

    Article  PubMed  CAS  Google Scholar 

  41. Guerin C, Gaillard S, Lemasson S, Ayzac L, Girard R, Beuret P, Palmier B, Le QV, Sirodot M, Rosselli S, Cadiergue V, Sainty JM, Barbe P, Combourieu E, Debatty D, Rouffineau J, Ezingeard E, Millet O, Guelon D, Rodriguez L, Martin O, Renault A, Sibille JP, Kaidomar M. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004;292:2379–2387.

    Article  PubMed  CAS  Google Scholar 

  42. Bein T. Weber F. Philipp A, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006;34:1372–77.

    Google Scholar 

  43. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159–165.

    Article  PubMed  CAS  Google Scholar 

  44. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–1684.

    Article  PubMed  CAS  Google Scholar 

  45. Winck JC, Azevedo L, Costa-Pereira A, et al. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary oedema – a systematic review and meta-analysis. Crit Care. 2006;10:R69.

    Article  PubMed  Google Scholar 

  46. Ferrer M, Esquinas A, Arancibia F et al. Noninvasive ventilation during persistent weaning failure. A randomized controlled trial. Am J Respir Crit Care Med. 2003;168:70–76.

    Article  PubMed  Google Scholar 

  47. Ram FSF, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004;3:CD004104.

    PubMed  Google Scholar 

  48. Rana S, Jenad H, Gay P et al. Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study. Crit Care. 2006;10:R79.

    Article  PubMed  Google Scholar 

  49. MacIntyre NR, Cook DJ, Ely EW Jr, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest. 2001;120(6Suppl):375S–395S

    Article  PubMed  CAS  Google Scholar 

  50. Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29:1033–56

    Article  PubMed  Google Scholar 

  51. Parikh CR, Sandmaier BM, Rainer F, Blume SK, Sahebi F, Maloney DG, Maris MB, Nieto Y, Edelstein CL, Schrier RW, McSweeney PJ. Acute Renal Failure after Nonmyeloablative Hematopoietic Cell Transplantation Am Soc Nephrol. 2004;15:1868–1876.

    Article  Google Scholar 

  52. Carmichael P, carmichael AR. acute renal failure in the surgical setting. ANZ J Surg. 2003;73(3):144–153.

    Article  PubMed  Google Scholar 

  53. Lameire N, Van Beisen W, Van holder R. Acute renal failure. Lancet. 2005;365:417–430.

    PubMed  CAS  Google Scholar 

  54. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16:162–168.

    Article  PubMed  Google Scholar 

  55. Wijeysundera DN, Karkouti K, Beattie WS, Rao V, Ivanov J. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology. 2006;104:65–72.

    Article  PubMed  Google Scholar 

  56. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367.

    Article  PubMed  Google Scholar 

  57. Wan L, Bellomo R, Giantomasso DD, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;9:496–502.

    Article  PubMed  Google Scholar 

  58. Warren HS, Suffredini AF, Eichacker PQ, Munford RS. Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med. 2002;347:1027–1030.

    Article  PubMed  Google Scholar 

  59. Krismer AC, Wenzel V, Mayr VD, Voelckel WG, Strohmenger HU, Lurie K, Lindner KH. Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: Current experience and future perspectives. Curr Opin Crit Care. 2001;7:157–169.

    Article  PubMed  CAS  Google Scholar 

  60. De Vriese S. Prevention and Treatment of Acute Renal Failure in Sepsis. J Am Soc Nephrol. 2003;14:792–805.

    Article  PubMed  Google Scholar 

  61. Lameire NH, De Vriese An S, Vanholder R. Prevention and nondialytic treatment of acute renal Failure Curr Opin Crit Care. 2003;9(6):481–490.

    Article  PubMed  Google Scholar 

  62. Knaus WA, Wagner DP, Draper EA. The APACHE III prognostic system. Risk predicton of hospital mortality for critically ill hospitalised adults. Chest. 1991;1100:1619–1636.

    Article  Google Scholar 

  63. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. and the ADQI workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R202–12.

    Article  Google Scholar 

  64. Gettings LG, Reynolds HN, Scalea T, Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early versus late. Intensive Care Med. 1999;25:805–13.

    Article  PubMed  CAS  Google Scholar 

  65. Wilkinson AH, Cohen DJ. Renal Failure in the Recipients of Nonrenal Solid Organ Transplants J Am Soc Nephrol. 1999;10:1136–1144.

    PubMed  CAS  Google Scholar 

  66. Metnitz PGH, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Critical Care Med. 2002;30:2051–2058.

    Google Scholar 

  67. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275(19):1489–1494.

    Article  PubMed  CAS  Google Scholar 

  68. Petroni KC, Cohen NH. Continuous Renal Replacement Therapy: Anaesthetic Implications Anesth Analg. 2002;94:1288–1297.

    Article  PubMed  Google Scholar 

  69. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med. 1986;314:97–105.

    Article  PubMed  CAS  Google Scholar 

  70. Van Bommel EFH, Leunissen KML, Weimar W. Continuous renal replacement therapy for critically ill patients: an update. J Intensive Care Med. 1994;9:265–80.

    PubMed  Google Scholar 

  71. Druml W. Metabolic aspects of continuous renal replacement therapies. Kidney Int. 1999;56:S56–61.

    Article  Google Scholar 

  72. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30.

    Article  PubMed  CAS  Google Scholar 

  73. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med. 2002;30:2205–2211.

    Article  PubMed  Google Scholar 

  74. Reeves JH, Cumming AR, Gallagher L, O’Brien JL, Santamaria JD. A controlled trial of low molecular- weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med. 1999;27:2224–2228.

    Article  PubMed  CAS  Google Scholar 

  75. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med. 1994;22:1774–1781.

    PubMed  CAS  Google Scholar 

  76. Vargas Hein O, von Heymann C, Lipps M, Ziemer S, Ronco C, Neumayer HH, Morgera S, Welte M, Kox WJ, Spies C. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med. 2001;27:673–679.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Devile, M., Patel, P., Gómez, C.M. (2009). Management of Multiorgan Failure After Artificial Organ Implantation. In: Hakim, N. (eds) Artificial Organs. New Techniques in Surgery Series, vol 4. Springer, London. https://doi.org/10.1007/978-1-84882-283-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-283-2_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-281-8

  • Online ISBN: 978-1-84882-283-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics